Molecular Human Reproduction, Vol. 5, No. 8, 726-731,
August 1999
© 1999 European Society of Human Reproduction and Embryology
FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms
1 Laboratory of Reproductive Biology, Section 5712, Juliane Marie Center for Children, Women and Reproduction, University Hospital of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, Denmark, 2 Department of Reproductive Biology, Instituto Nacional de la Nutricion Salvador Zubiran, Mexico City, Mexico, and 3 Wallaceville Animal Research Centre, Upper Hutt, New Zealand
The ability of different isoforms of follicle stimulating hormone (FSH) to induce the resumption of meiosis in cultured mouse oocytes was evaluated. Oocytes were cultured in the presence of hypoxanthine to prevent spontaneous resumption of meiosis. Using serial dilutions of the isoform fractions representing less acidic isoforms (pI 6.435.69), mid-acidic (pI 5.624.96) and acidic (pI 4.693.75), the concentration which caused 50% of the oocytes to resume meiosis and undergo germinal vesicle breakdown (GVBD) after a culture period of 24 h (i.e. ED50% GVBD) was determined. The FSH concentration of the isoform fractions was determined by radioimmunoassay, radio-receptor assay or through cAMP release in a Chinese hamster ovary-cell line expressing the human FSH-receptor. Determined by radioimmunoassay, the (ED50% GVBD) values were: less acidic 6.4 ± 0.3 IU/l (mean ± SD), mid-acidic 6.1 ± 0.7 IU/l and acidic 12.2 ± 0.7 IU/l. The less and mid-acidic isoforms were significant lower than the acidic (P < 0.0005). Similar relationships between the isoform fractions were obtained by the two other FSH assays. The results demonstrate that FSH isoforms with a pI of >5.0 induced resumption of meiosis significantly more efficiently than acidic isoforms. Less and mid-acidic isoforms may exert an important physiological function by inducing the resumption of meiosis in oocytes from pre-ovulatory follicles during the mid-cycle gonadotrophin surge.
FSH isoforms/meiosis/mouse oocytes
4 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Humaidan, H. Ejdrup Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, L. Westergaard, and C. Yding Andersen GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum. Reprod., May 1, 2005; 20(5): 1213 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ulloa-Aguirre, C. Timossi, J. Barrios-de-Tomasi, A. Maldonado, and P. Nayudu Impact of Carbohydrate Heterogeneity in Function of Follicle-Stimulating Hormone: Studies Derived from in Vitro and in Vivo Models Biol Reprod, August 1, 2003; 69(2): 379 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perlman, B. van den Hazel, J. Christiansen, S. Gram-Nielsen, C. B. Jeppesen, K. V. Andersen, T. Halkier, S. Okkels, and H. T. Schambye Glycosylation of an N-Terminal Extension Prolongs the Half-Life and Increases the in Vivo Activity of Follicle Stimulating Hormone J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3227 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Mitchell, C. R. Kennedy, and G. M. Hartshorne Effects of varying gonadotrophin dose and timing on antrum formation and ovulation efficiency of mouse follicles in vitro Hum. Reprod., May 1, 2002; 17(5): 1181 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, J. Itskovitz-Eldor, and H. G. van Hooren Endocrine Profiles after Triggering of Final Oocyte Maturation with GnRH Agonist after Cotreatment with the GnRH Antagonist Ganirelix during Ovarian Hyperstimulation for in Vitro Fertilization J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 709 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. A. Vitt, P. L. Nayudu, U. M. Rose, and H. J. Kloosterboer Embryonic Development after Follicle Culture Is Influenced by Follicle-Stimulating Hormone Isoelectric Point Range Biol Reprod, November 1, 2001; 65(5): 1542 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Walton, V. T. Nguyen, V. Y. Butnev, V. Singh, W. T. Moore, and G. R. Bousfield Characterization of Human FSH Isoforms Reveals a Nonglycosylated {beta}-Subunit in Addition to the Conventional Glycosylated {beta}-Subunit J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3675 - 3685. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ulloa-Aguirre, C. Timossi, and J.P. Mendez Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: I. Gondatrophins are synthesized and released in multiple molecular forms. A matter of fact Hum. Reprod., April 1, 2001; 16(4): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Cavilla, C.R. Kennedy, M. Baltsen, L.D. Klentzeris, A.G. Byskov, and G.M. Hartshorne The effects of meiosis activating sterol on in-vitro maturation and fertilization of human oocytes from stimulated and unstimulated ovaries Hum. Reprod., March 1, 2001; 16(3): 547 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.Y. Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, K.S. Kristensen, and A.G. Byskov Effect of different FSH isoforms on cyclic-AMP production by mouse cumulus-oocyte-complexes: a time course study Mol. Hum. Reprod., February 1, 2001; 7(2): 129 - 135. [Abstract] [Full Text] [PDF] |
||||



